SEARCH

SEARCH BY CITATION

References

  • 1
    Strasberg SM, Howard TD, Molmenti EP, Hertl M. Selecting the donor liver: Risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20:829838.
  • 2
    Doyle HR, Marino IR, Jabbour N, Zetti G, McMichael J, Mitchell S, et al. Early death or retransplantation in adults after orthotopic liver transplantation. Transplantation 1994; 57:10281036.
  • 3
    Avolio AW, Agnes S, Chirico ASA, Castagneto M. Primary dysfunction after liver transplantation: Donor or recipient fault? Transplant Proc 1999; 31:434436.
  • 4
    Bilbao I, Charco R, Hidalgo E, Lazaro JL, Balsells J, Murio E, Margarit C. Risk factors for severe ischemic injury after liver transplantation. Transplant Proc 1997; 29:368370.
  • 5
    Pokorny H, Gruenberger T, Soliman T, Rockenschaub S, Langle F, Steininger R. Organ survival after primary dysfunction of liver grafts in clinical orthotopic liver transplantation. Transpl Int 2000; 13(suppl):S154S157.
  • 6
    Ploeg RJ, D'Alessandro A, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, et al. Risk factors for primary dysfunction after liver transplantation—A multivariate analysis. Transplantation 1993; 55:807813.
  • 7
    Porte RJ, Ploeg RJ, Hansen B, Van Bockel JH, Thorogood J, Persijn GG, et al. Long-term graft survival after liver transplantation in the UW era: Late effects of cold ischemia and primary dysfunction. Transpl Int 1998; 11(suppl 1):S164S167.
  • 8
    Cofer JB, Klintmalm GB, Howard TK, Morris CV, Husberg BS, Goldstein RM, Gonwa TA. A comparison of UW with Eurocollins preservation solution in liver transplantation. Transplantation 1990; 49:10881093.
  • 9
    Menasché P, Termignon JL, Pradier F, Grousset C, Mouas C, Alberici G, et al. Experimental evaluation of Celsior®, a new heart preservation solution. Eur J Cardiothorac Surg 1994; 8:207213.
  • 10
    Roberts RF, Nishanian GP, Carey JN, Sakamaki Y, Starnes VA, Barr ML. A comparison of the new preservation solution Celsior to Euro-Collins and University of Wisconsin in lung reperfusion injury. Transplantation 1999; 67:152155.
  • 11
    Baldan N, Toffano M, Cadrobbi R, Codello L, Calabrese F, Bacelle L, Rigotti P. Kidney preservation in pigs using a new organ preservation solution. Transplant Proc 1997; 29:35393540.
  • 12
    Minor T, Vollmar T, Menger MD, Isselhard W. Cold preservation of the small intestine with the new-Celsior solution. Transpl Int 1998; 11:3237.
  • 13
    Baldan N, Rigotti P, Furian L, Valente ML, Calabrese F, Di Filippo L, et al. Pancreas preservation with Celsior solution in a pig autotransplantation model: Comparative study with University of Wisconsin solution. Transplant Proc 2001; 33:873875.
  • 14
    Maggi U, Caccamo L, Gatti S, Paone G, Reggiani P, Rossi G, et al. Celsior solution and clinical liver transplantation. Transplant Proc 2000; 32:3637.
  • 15
    Hefty T, Fraser S, Nelson K, Bennett W, Barry J. Comparison of UW and Euro-Collins solutions in paired cadaveric kidneys. Transplantation 1991; 53:491492.
  • 16
    Nardo B, Bellusci R, de Badiali GL, Pasquinelli G, Ferlaino F, de Raffele E, et al. Ultrastructural aspects of the iliac arteries of multiorgan donor preserved in University of Wisconsin solution for 48 hours. Transplant Proc 1992; 24:20772078.
  • 17
    Cavallari A, Nardo B, Pasquinelli G, Badiali de Giorgi L, Bellusci R, Ferlaino F, et al. Subcellular lesions of the biliary tract in human liver transplants incurred during preservation. Transplant Proc 1992; 24:19791980.
  • 18
    Susimoto R, Lindeli SL, Southard JH, Belzer FO. A comparison of histidine-lactobionate and UW solution in 48-hour dog liver preservation. Transplantation 1992; 54:610614.
  • 19
    Pisarenko OI, Solomatina ES, Ivanov VE, Studneva IM, Kapelko VI, Smirnov VN. On the mechanism of enhanced ATP formation in hypoxic myocardium caused by glutamic acid. Basic Res Cardiol 1985; 80:126134.
  • 20
    Nardo B, Catena F, Cavallari G, Montalti R, Di Naro A, Faenza A, Cavallari A. Randomized clinical study comparing UW and Celsior solution in liver preservation for transplantation: Preliminary results. Transplant Proc 2001; 33:870872.
  • 21
    Tolba RH, Akbar S, Puetz U, Minor T. Current organ preservation solution for liver preservation: Experimental comparison. Transplant Proc 2000; 32:16731674.
  • 22
    Howden BO, Jablonski P. Liver preservation: A comparison of Celsior to colloid-free University of Wisconsin solution. Transplantation 2000; 70:11401142.
  • 23
    Valero R, Almenara R, Garcia-Valdecasas JC, Beltran J, Net M, Capdevila L, et al. Usefulness of Celsior in graft preservation of livers obtained from non heart beating donors in experimental (pigs) liver transplantation: Comparative study with University of Wisconsin solution. Transplant Proc 1999; 31:24332434.
  • 24
    Audet M, Alexandre E, Mustun A, David P, Chenard-Neu MP, Tiollier J, et al. Comparative evaluation of Celsior solution versus Viaspan in a pig liver transplantation model. Transplantation 2001; 71:17311735.
  • 25
    Ohwada S, Sunose Y, Tsutsumi H, Iwazaki S, Aiba M, Kasahara M, et al. Celsior is superior to UW for graft preservation from non-heart-beating donors in a canine liver transplantation model. Transplant Proc 2001; 33:922923.